And on the operations side....
The COO publicly stating that ALL ADAPT products were experiencing a breakout in sales
AND
The CEO publicly stating that the expanded access program for CardioCel 3D, a one of a kind product which only Admedus can create and manufacture.... "The progress to date on CardioCel 3D has been excellent and the current user feedback from our surgeons is extremely promising,”
Answers from WP - a good read, page-178
-
- There are more pages in this discussion • 138 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$18.31 |
Change
-0.240(1.29%) |
Mkt cap ! $351.9M | |||
| Open | High | Low | Value | Volume |
| $18.80 | $19.15 | $18.20 | $159.7K | 8.611K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 73 | $18.31 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.33 | 90 | 1 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| AVR (ASX) Chart |